Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Xebra Brands Ltd (2): Xebra Brands cancels LOI to acquire BSK | 4 | Stockwatch | ||
Do | Xebra Brands Ltd. Terminates Letter of Intent to Acquire BSK Holdings Inc.; Announces Delay in Completion of Annual Filings and MCTO; Announces Loan | 301 | ACCESS Newswire | Continued Partnership to Bring ELEMENTS CBD Product Line to U.S. Market VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0)... ► Artikel lesen | |
24.06. | Xebra Brands Ltd (2): Xebra Brands clarifies not-yet-granted MCTO | 7 | Stockwatch | ||
23.06. | Xebra Brands Ltd: Xebra Announces Corporate Update and Correction Notice of Press Release Announcing Grant of Management Cease Trade Order | 303 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Xebra Brands Ltd. (CSE:XBRA) (the "Company" or "Xebra Brands") announces a correction to the Company's press release dated June 23, 2025 announcing... ► Artikel lesen | |
23.06. | Xebra Brands Ltd (2): Xebra Brands to be late to file fiscal 2025 results | 2 | Stockwatch | ||
XEBRA BRANDS Aktie jetzt für 0€ handeln | |||||
23.06. | Xebra Brands Ltd: Xebra Announces Delay in Filing Financial Statements | 200 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Xebra Brands Ltd. ("Xebra") (XBRA:CSE)(XBRAF:OTCQB)(9YC:FSE), announces today that it was not in a position to file its audited annual financial statements... ► Artikel lesen | |
13.05. | Xebra Brands Ltd (2): Xebra to launch Elements CBD line in U.S. this summer | 4 | Stockwatch | ||
13.05. | Xebra Brands Ltd: Xebra Brands Advances Commercialization Efforts with NF Skin | 223 | ACCESS Newswire | Summer 2025 Launch of ELEMENTS CBD Product Line in United States VANCOUVER, BC / ACCESS Newswire / May 13, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading... ► Artikel lesen | |
25.04. | Xebra Brands Ltd (2): Xebra Brands enters LOI to acquire BSK Holdings | 4 | Stockwatch | ||
24.04. | XFRA 9YC0: WIEDERAUFNAHME/RESUMPTION | 280 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
24.04. | Xebra Brands Ltd (2): Xebra Brands to resume at 8 a.m. PT | 3 | Stockwatch | ||
24.04. | Xebra Brands Ltd: Xebra Brands Announces Letter of Intent to Acquire CBD E-Commerce Company BSK Holdings Inc. | 395 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, BC / ACCESS... ► Artikel lesen | |
23.04. | XFRA 9YC0: AUSSETZUNG/SUSPENSION | 622 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILXEBRA BRANDS CL.A... ► Artikel lesen | |
23.04. | Xebra Brands Ltd (2): Xebra Brands halted at 7:48 a.m. PT | 6 | Stockwatch | ||
15.04. | Xebra Brands Ltd (2): Xebra Brands strikes partnership for U.S. CBD launch | 3 | Stockwatch | ||
15.04. | Xebra Brands Ltd: Xebra Brands Executes Manufacturing and Distribution Agreement to Launch CBD Product Line in the U.S. | 297 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / April 15, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading innovator in the North American cannabis sector, is pleased... ► Artikel lesen | |
10.04. | Xebra Brands Ltd (2): Xebra calls out for partners of all stripe in Mexico | 3 | Stockwatch | ||
10.04. | Xebra Brands Ltd: Xebra Brands Launches National RFP to Establish Cannabis Cultivation Partnerships Across Mexico | 326 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / April 10, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a trailblazer in the Mexican cannabis sector and the sole company legally... ► Artikel lesen | |
08.04. | Xebra Brands Ltd (2): Xebra talks North American focus amid tariff talk | 2 | Stockwatch | ||
08.04. | Xebra Brands touts tariff resilience | 1 | The Market Herald Canada |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 26,195 | +0,56 % | Übernahmefieber! BioTech und Künstliche Intelligenz beflügelt Evotec, NetraMark Holdings, NovoNordisk und Bayer | Derzeit erlebt der Biotech-Sektor eine spannende Transformation: Denn Big Data und Künstliche Intelligenz verändern in rasanter Art und Weise, wie neue Medikamente entdeckt, entwickelt und getestet... ► Artikel lesen | |
AURORA CANNABIS | 3,880 | 0,00 % | Aurora Cannabis Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
CANOPY GROWTH | 1,120 | +0,90 % | Canopy Growth Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
TILRAY BRANDS | 0,428 | +0,59 % | Here's why the Tilray Brands stock price has imploded | ||
INNOCAN PHARMA | 0,136 | -0,37 % | Breaking News: Treibstoff für den Turnaround-Turbo?! | ||
CRONOS GROUP | 1,741 | 0,00 % | Cronos Group Inc: Cronos Group expands distribution with Peace Naturals | ||
SYNBIOTIC | 3,185 | +1,27 % | SYNBIOTIC SE: Update von der mwb-Konferenz: Diversifiziertes Geschäftsmodell gewinnt an Dynamik; mwb research empfiehlt KAUFEN | Auf der mwb research Health Care Conference bekräftigten CEO Daniel Kruse und sein Team den strategischen Fokus von SYNBIOTIC auf ein plattformbasiertes Buy-and-Build-Modell in wachstumsstarken Cannabis-... ► Artikel lesen | |
NEKTAR THERAPEUTICS | 19,500 | -3,70 % | Nektar Therapeutics Prices $100 Mln Public Offering Of Common Stock At $23.50 Per Share | WASHINGTON (dpa-AFX) - Nektar Therapeutics (NKTR), a clinical-stage biotech firm specializing in immunotherapy, has priced its underwritten public offering of approximately $100 million in common... ► Artikel lesen | |
ORAMED PHARMACEUTICALS | 1,819 | -0,63 % | Oramed Pharmaceuticals Inc.: Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical | Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology
Accelerating multiple late-stage cancer therapies... ► Artikel lesen | |
OPKO HEALTH | 1,121 | -1,22 % | OPKO Health, Inc.: OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting | MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) ("Entera") today announced that new pharmacologic and pharmacokinetic in vivo... ► Artikel lesen | |
JAGUAR HEALTH | 2,560 | 0,00 % | Jaguar Health, Inc.: Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient | As recently announced, initial proof-of-concept results from this ongoing investigator-initiated trial (IIT) show crofelemer reduced the required total parenteral nutrition in the first participating... ► Artikel lesen | |
SELLAS LIFE SCIENCES | 1,816 | -1,09 % | SELLAS Life Sciences Group, Inc.: SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting | - ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer - - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in... ► Artikel lesen | |
XORTX THERAPEUTICS | 0,730 | -4,95 % | XORTX gibt 3-Millionen-USD-Platzierung bekannt | - Erlös wird für die Weiterentwicklung der XORTX-Programme zur Gichtbehandlung verwendet -
CALGARY, AB, 19. Mai 2025 / IRW-Press / XORTX Therapeutics Inc. ("XORTX" oder das "Unternehmen")... ► Artikel lesen | |
NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA LR23: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUMINUS WELLNESS... ► Artikel lesen | |
CANNOVUM CANNABIS | 0,250 | 0,00 % | EQS-News: Cannovum Cannabis AG: Abwicklung bzw. Veräußerung der Beteiligungen im Cannabis-Bereich | EQS-News: Cannovum Cannabis AG
/ Schlagwort(e): Strategische Unternehmensentscheidung/Sonstiges
Cannovum Cannabis AG: Abwicklung bzw. Veräußerung der Beteiligungen im Cannabis-Bereich... ► Artikel lesen |